Similarly, blocking TLR4 at the onset of infection induced mortality from otherwise non-lethal peritonitis, while therapeutic administration of anti-TLR4 antibodies protected mice from lethal Gram-negative bacterial sepsis (299). The gene discussed is TLR4; the disease is peritonitis.